Goodman M T, McDuffie K, Hernandez B, Wilkens L R, Bertram C C, Killeen J, Le Marchand L, Selhub J, Murphy S, Donlon T A
Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii 96813, USA.
Cancer Epidemiol Biomarkers Prev. 2001 Dec;10(12):1275-80.
Epidemiological studies have been inconsistent regarding a role for folate in the etiology of cervical dysplasia. Methylenetetrahydrofolate reductase (MTHFR) catalyzes the synthesis of 5-methyltetrahydrofolate, which is involved in the methylation of homocysteine to methionine. A common variant of this enzyme, resulting from a 677C-->T (Ala-->Val) substitution in the gene, has been shown to have reduced activity and is associated with mild hyperhomocysteinemia. A multiethnic case-control study was used to examine the association of dietary folate and MTHFR genotype with the odds ratios (ORs) for cervical dysplasia among women identified from several clinics on Oahu, Hawaii, between 1992 and 1996. We collected blood samples for DNA extraction, cervical smears for cytological diagnosis, exfoliated cervical cells for human papillomavirus (HPV) DNA testing, and personal interviews from 150 women with squamous intraepithelial lesions (SILs) and from 179 women with cytologically normal (Pap) smears. We found a positive, monotonic trend (P = 0.02) in the ORs for cervical SILs associated with the number of variant MTHFR T alleles, after multivariate adjustment. Women with the heterozygous CT genotype had twice the risk of cervical SILs [OR, 2.0; 95% confidence interval (CI), 1.1-3.7], and women with the homozygous TT genotype had almost three times the risk of SILs (OR, 2.9; 95% CI, 1.0-8.8) compared to women with the homozygous MTHFR CC genotype. The dietary intakes of folate, vitamin B(6), and vitamin B(12) were inversely related to the ORs for cervical SILs, after adjustment for HPV DNA and other confounders. The OR among women in the highest quartile compared with women in the lowest quartile of folate intake was 0.3 (95% CI, 0.1-0.7; P for trend = 0.002). Women with the variant T allele and folate intakes below the median were at significantly elevated risk of cervical SILs (OR, 5.0; 95% CI, 2.0-12.2) compared to women with CC alleles and folate intakes above the median. HPV infection was a strong risk factor for cervical dysplasia, particularly among women with the variant T allele (OR, 46.6; 95% CI, 15.9-136.2). All associations of MTHFR genotype with the ORs for cervical SILs were independent of other risk factors under study. These findings suggest that the MTHFR T allele and reduced dietary folate may increase the risk for cervical SILs.
关于叶酸在宫颈发育异常病因学中的作用,流行病学研究结果并不一致。亚甲基四氢叶酸还原酶(MTHFR)催化5-甲基四氢叶酸的合成,该物质参与同型半胱氨酸向蛋氨酸的甲基化过程。该酶的一种常见变异体,是由基因中677C→T(丙氨酸→缬氨酸)替换导致的,已被证明活性降低,并与轻度高同型半胱氨酸血症相关。一项多民族病例对照研究,用于检验1992年至1996年间在夏威夷瓦胡岛多家诊所确诊的女性中,膳食叶酸和MTHFR基因型与宫颈发育异常比值比(OR)之间的关联。我们采集血样用于DNA提取,采集宫颈涂片用于细胞学诊断,采集脱落的宫颈细胞用于人乳头瘤病毒(HPV)DNA检测,并对150名患有鳞状上皮内病变(SIL)的女性和179名细胞学涂片正常(巴氏涂片)的女性进行了个人访谈。多变量调整后,我们发现与MTHFR T等位基因变异数量相关的宫颈SIL的OR呈正的单调趋势(P = 0.02)。与纯合MTHFR CC基因型的女性相比,杂合CT基因型的女性患宫颈SIL的风险是其两倍[OR,2.0;95%置信区间(CI),1.1 - 3.7],而纯合TT基因型的女性患SIL的风险几乎是其三倍(OR,2.9;95% CI,1.0 - 8.8)。在调整HPV DNA和其他混杂因素后,叶酸、维生素B6和维生素B12的膳食摄入量与宫颈SIL的OR呈负相关。叶酸摄入量处于最高四分位数的女性与最低四分位数的女性相比,OR为0.3(95% CI,0.1 - 0.7;趋势P = 0.002)。与携带CC等位基因且叶酸摄入量高于中位数的女性相比,携带变异T等位基因且叶酸摄入量低于中位数的女性患宫颈SIL的风险显著升高(OR,5.0;95% CI,2.0 - 12.2)。HPV感染是宫颈发育异常的一个强风险因素,特别是在携带变异T等位基因的女性中(OR,46.6;95% CI,15.9 - 136.2)。MTHFR基因型与宫颈SIL的OR之间的所有关联均独立于所研究的其他风险因素。这些发现表明,MTHFR T等位基因和膳食叶酸减少可能会增加患宫颈SIL的风险。